{
    "clinical_study": {
        "@rank": "46963", 
        "arm_group": {
            "arm_group_label": "patients", 
            "description": "Patients (Aged 18 to 70 inclusive) with progressive colorectal cancer in intra-abdominal surgery requiring resection +/- Chemotherapy Hyperthermic Intraperitoneal"
        }, 
        "brief_summary": {
            "textblock": "Between 30% and 40% of patients with colorectal cancer develop metastatic disease\n      intraperitoneally. The optimal treatment of this disease combines surgery and chemotherapy\n      but requires resection of all lesions larger than 2mm.\n\n      Indocyanine green has an affinity for tumor tissues and the interest of its use has been\n      demonstrated for the detection of sentinel lymph node and some liver surgeries.\n\n      The ability of indocyanine green to detect peritoneal carcinomatosis in humans has never\n      been evaluated.\n\n      This study aims to evaluate the diagnostic performance of fluorescence in the detection of\n      malignant cells in peritoneal carcinomatosis of colorectal origin compared with pathological\n      analysis."
        }, 
        "brief_title": "Monocentric Prospective Pilot Study Evaluating the Value of Indocyanine Green (ICG, Indocyanine Green) During a Surgical Resection of Cancerous Lesions Peritoneal Colorectal Origin.", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Colorectal Cancer Metastatic", 
        "condition_browse": {
            "mesh_term": [
                "Colorectal Neoplasms", 
                "Neoplasms"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patient with progressive colorectal cancer in intra-abdominal surgery requiring\n             resection + / - Chemotherapy Hyperthermic Intraperitoneal\n\n          -  Aged 18 to 70 inclusive\n\n          -  Signature information form and consent by the patient\n\n        Exclusion Criteria:\n\n          -  Pregnant women, a urine pregnancy test or blood will be realized within 72 hours\n             before surgery\n\n          -  Contraindication to surgery\n\n          -  Diagnosis not confirmed colorectal adenocarcinoma\n\n          -  Persons major subject of legal protection or unable to consent"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patient with progressive colorectal cancer in intra-abdominal surgery requiring resection\n        +/- Chemotherapy Hyperthermic Intraperitoneal"
            }
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 6, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01982227", 
            "org_study_id": "1208138", 
            "secondary_id": "2012-004314-34"
        }, 
        "intervention": {
            "arm_group_label": "patients", 
            "description": "intravenous injection (0.25mg/kg) of the indocyanine green 24h before the surgery.", 
            "intervention_name": "indocyanine green", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "colorectal cancer metastatic", 
            "indocyanine green"
        ], 
        "lastchanged_date": "November 13, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Saint-etienne", 
                    "country": "France", 
                    "zip": "42055"
                }, 
                "name": "CHU de Saint-Etienne"
            }, 
            "investigator": {
                "last_name": "Gabrielle BARABINO, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_groups": "1", 
        "official_title": "Monocentric Prospective Pilot Study Evaluating the Value of Indocyanine Green (ICG, Indocyanine Green) During a Surgical Resection of Cancerous Lesions Peritoneal Colorectal Origin.", 
        "overall_contact": {
            "email": "gabrielle.barabino@chu-st-etienne.fr", 
            "last_name": "Gabrielle BARABINO, MD", 
            "phone": "(0)477127717", 
            "phone_ext": "+33"
        }, 
        "overall_official": {
            "affiliation": "CHU de Saint-Etienne", 
            "last_name": "Gabrielle BARABINO, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "France: French Data Protection Authority", 
                "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Sensitivity (true positive) of the fluorescence ex vivo compared to histological analysis s detected by fluorescence ex vivo", 
            "measure": "Sensitivity (true positive) of the fluorescence ex vivo compared to histological analysis s detected by fluorescence ex vivo", 
            "safety_issue": "No", 
            "time_frame": "At the end of the surgery"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01982227"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Specificity (true negative) of the in-vivo fluorescence compared to histological analysis s detected by fluorescence ex vivo PCI score with and without fluorescence", 
                "measure": "Specificity (true negative) of the in-vivo fluorescence compared to histological analysis s detected by fluorescence ex vivo peritoneal cancer index  (PCI) score with and without fluorescence", 
                "safety_issue": "No", 
                "time_frame": "At the end of the surgery"
            }, 
            {
                "description": "Specificity (true negative) of the in-vivo fluorescence compared to histological analysis s detected by fluorescence ex vivo PCI score with and without fluorescence", 
                "measure": "Specificity (true negative) of the in-vivo fluorescence compared to histological analysis s detected by fluorescence ex vivo PCI score with and without fluorescence", 
                "safety_issue": "No", 
                "time_frame": "At de begining of the surgery"
            }
        ], 
        "source": "Centre Hospitalier Universitaire de Saint Etienne", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Centre Hospitalier Universitaire de Saint Etienne", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "November 2013"
    }
}